DALLAS--([ BUSINESS WIRE ])--Former United States Securities and Exchange Commission attorney [ Willie Briscoe ] and the securities litigation firm of [ Powers Taylor, LLP ] are investigating the sale of ZOLL Medical Corporation (aZOLLa) (NASDAQ: ZOLL) to Asahi Kasei Corporation for shareholders. Under the proposed transaction, ZOLL shareholders will receive $93.00 for each share of ZOLL stock owned.
If you are an affected investor, and you want to learn more about the lawsuit or join the action, contact Patrick Powers at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at [ patrick@powerstaylor.com ], or Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at [ WBriscoe@TheBriscoeLawFirm.com ]. There is no cost or fee to you.
The definitive merger agreement involves an all cash transaction with a total equity value of approximately $2.2 billion. The deal is expected to close in the second quarter of 2012.
At least one analyst has set a price target of $100.00 per share for ZOLLas stock. Therefore, the investigation centers on whether ZOLL shareholders are receiving adequate compensation for their shares in the buyout, whether the transaction undervalues ZOLL stock, and whether ZOLLas board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal.
[ The Briscoe Law Firm, PLLC ] is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.
[ Powers Taylor, LLP ] is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.